AMD
How OCT is improving early characterization of GA lesions
A comparison of B-scan and en face imaging techniques for diagnosis of early macular atrophy.
CST changes and VA in nAMD: A review of the evidence
Post-hoc analyses and real-world studies demonstrate the link between central subfoveal thickness fluctuations and visual acuity in neovascular age-related macular degeneration.
Metformin’s potential impact on AMD prevention
Multiple observational studies have shown the potential of the antidiabetic drug in the management of age-related macular degeneration.
Reframing the discussion around geographic atrophy
Understanding the natural disease progression will help us talk to our patients about new and emerging treatments.
Understanding the risk of GA in nAMD
A look at research that sheds new light into the progression of geographic atrophy in neovascular age-related macular degeneration.
Update on mitochondrial stabilizers
Also from the Angiogenesis, Exudation, and Degeneration meeting, emerging treatments for nAMD and MacTel2, and a marker for anti-VEGF success in ROP.
Axitinib implant shows early potential
Interim results from Phase I trial of OTX-TKI, a bioresorbable hydrogel platform using a tyrosine kinase inhibitor.
AAO Report: New insights into ILM tears, trial readouts and more
Five abstracts on gene therapy and role of central subfield thickness in diabetic macular edema, vitreous hemorrhage and retinopathy of prematurity.
Treat and extend: An international view
Three experts from Canada, Switzerland and Israel provide insights into the nuances of adherence, treatment intervals and emerging therapies.
A closer look at emerging drug-delivery platforms
An update on Port Delivery System with ranibizumab, a large-molecule anti-VEGF candidate and subretinal gene therapy to treat neovascular AMD.
Current Issue
Continuing Medical Education
Additional Publications
Tuesday, October 8, 2024 | Learn More About Stargardt Disease
Location: Webinar
Time: 7:00 PM ET
Time: 7:00 PM ET
Speaker: Lejla Vajzovic, MD, FASRS
Sponsored by Alkeus Pharmaceuticals, Inc.
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
